How much funding has Psyadon Pharmaceuticals raised?

Psyadon Pharmaceuticals has raised $8.0M in total funding, most recently a Venture Round.

When was Psyadon Pharmaceuticals founded?

Psyadon Pharmaceuticals was founded in 2004.

Where is Psyadon Pharmaceuticals headquartered?

Psyadon Pharmaceuticals is headquartered in Germantown, Maryland, United States.

What industry is Psyadon Pharmaceuticals in?

Psyadon Pharmaceuticals operates in Biotech, CNS.

How many employees does Psyadon Pharmaceuticals have?

Psyadon Pharmaceuticals has 1-10 employees.

Psyadon Pharmaceuticals

Q: Who are Psyadon Pharmaceuticals's investors?

Psyadon Pharmaceuticals's investors include New Enterprise Associates, Alexandria Venture Investments, Pfizer Ventures.

Acquired

Germantown, United States · Founded 2004 · $8.0M raised

Biotech

CNS

Headquarters: Germantown, Maryland
Employees: 1–10
Founded: 2004
Business Model: B2B

Website: psyadonrx.com
Total Funding: $8.0M
Last Round: $8.0M Venture RoundAug 2018
Rounds: 2

About

Psyadon Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing treatments for rare and serious neurological disorders, most notably Tourette syndrome. The company has conducted clinical trials for ecopipam, a selective dopamine D1/D5 receptor antagonist being investigated as a potential treatment for Tourette syndrome in both pediatric and adult populations. Based in Germantown, Maryland, Psyadon operates as a small, focused drug development organization targeting underserved CNS conditions where current treatment options remain limited.

Summary

Psyadon Pharmaceuticals is a Biotech company based in Germantown, United States, founded in 2004. It has raised $8.0M in total across 2 rounds, most recently a $8.0M Venture Round round in Aug 2018. Investors include New Enterprise Associates, Alexandria Venture Investments and Pfizer Ventures.